A Clinical Trial to Determine the Safety and Efficacy of HB-adMSCs to Provide Protection Against COVID-19
Clinical trial NCT04349631 · COMPLETED
Trial details
- NCT number
- NCT04349631
- Sponsor
- Hope Biosciences Research Foundation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-20
- Primary completion
- 2020-11-25
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.